ArticleMolecular and cellular biology2006

TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.

Florence Gizard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.